Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006-05)
Author(s):
Blok, E.J.; Velde, C.J.H. van de (0000-0003-0104-1800); Kranenbarg, E.M.M.K.; Putter, H.; Bosch, J. van den; Maartense, E.; Leeuwen-Stok, A.E. van; Liefers, G.J.; Nortier, J.W.R.; Rutgers, E.J.T.; Kroep, J.R.
